Gohr, K., Hamacher, A., Engelke, L. H., & Kassack, M. U. (2017). Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38. BMC Cancer.
Chicago-стиль цитированияGohr, Katharina, Alexandra Hamacher, Laura H. Engelke, and Matthias U. Kassack. "Inhibition of PI3K/Akt/mTOR Overcomes Cisplatin Resistance in the Triple Negative Breast Cancer Cell Line HCC38." BMC Cancer 2017.
MLA-цитированиеGohr, Katharina, Alexandra Hamacher, Laura H. Engelke, and Matthias U. Kassack. "Inhibition of PI3K/Akt/mTOR Overcomes Cisplatin Resistance in the Triple Negative Breast Cancer Cell Line HCC38." BMC Cancer 2017.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.